Technology | Medical 3-D Printing | March 23, 2018

Materialise First Company to Receive FDA Clearance for Diagnostic 3-D-Printed Anatomical Models

FDA clearance supports the continued growth of point-of-care 3-D printing facilities

Materialise First Company to Receive FDA Clearance for Diagnostic 3-D-Printed Anatomical Models

March 23, 2018 — Materialise NV became the first company in the world to receive U.S. Food and Drug Administration (FDA) clearance for software intended for 3-D printing anatomical models for diagnostic use. The company said leading hospitals are adopting integrated 3-D printing services as part of their medical practices as they recognize the added value it brings to personalized patient care.

In August 2017, the FDA announced that software intended to create output files used for printing 3-D patient-specific anatomical models used for diagnostic purposes is a Class II medical device and requires regulatory clearance. Materialise is the first company to provide software that conforms to these regulations and that can be used in U.S. hospitals in combination with a compatible 3-D printer. Materialise Mimics inPrint software is used for pre-operative planning and the fabrication of physical models for diagnostic purposes, including patient management, treatment and surgeon-to-surgeon communication.

Frank J. Rybicki, M.D., Ph.D., chief of medical imaging at Ottawa Hospital, Ontario, Canada, said: “510k clearance is an essential component to ensure quality and safety in the practice of anatomical modeling in hospitals. This milestone for Materialise serves as a benchmark for the clinical implementation of 3-D printing for physicians creating 3D models at the point-of-care.”

The FDA clearance supports the creation of point-of-care 3-D printing facilities in hospitals. Anatomical models help surgeons to make better-informed decisions and to accurately plan their surgeries. They are also used to enhance education and communication between multidisciplinary teams and with the patient. Materialise said an increasing number of hospitals across the U.S. have integrated the practice of 3-D printing in their medical care and are creating point-of-care 3-D printing facilities. Out of the top 20 U.S. hospitals (as ranked by the U.S. News and World Report), 16 have reportedly implemented a medical 3-D printing strategy using Materialise Mimics technology.

For more information: www.materialise.com

 

Related Content

Videos | Enterprise Imaging | September 03, 2021
ITN Editor Dave Fornell collected numerous examples of how...
Canon's Vitrea PACS enterprise imaging system was one of several systems demonstrated at HIMSS 2021 that had easily modified hanging protocols. This included ease of use to customize what each radiologists prefers, including slice thickness. #HIMSS #HIMSS21

Canon's Vitrea PACS enterprise imaging system was one of several systems demonstrated at HIMSS 2021 that had easily modified hanging protocols. This included ease of use to customize what each radiologists prefers, including slice thickness. Photo by Dave Fornell

Feature | Enterprise Imaging | September 02, 2021 | By Dave Fornell, Editor
Taking advantage of new technology advances, several ...
SyntheticMR and Siemens Healthineers signed a cooperation agreement in 2016, since 2018, SyMRI NEURO has been available for purchase on the Siemens Healthineers Digital Marketplace. The product can be seamlessly integrated in the clinical workflow.
News | Advanced Visualization | August 17, 2021
August 17, 2021 — SyntheticMR and Siemens Healthineers signe
#coronavirus #COVID19 #pandemic #RSNA21 will require all attendees and exhibitors to show proof of #vaccination and wear a #mask

Getty Images

News | RSNA | August 12, 2021
August 12, 2021 — RSNA 2021 will require proof of CO...
An example of HeartFlow's FFR-CT analysis of blockage severity in a patient's coronary vessels based on a cardiac CT scan.

An example of HeartFlow's FFR-CT analysis of blockage severity in a patient's coronary vessels based on a cardiac CT scan.

News | Cardiac Imaging | July 15, 2021
July 15, 2021 — HeartFlow, which has commercialized noninvasive...
HIMSS21 is a COVID-19 Vaccination Required Event for all attendees, exhibitors, and HIMSS staff

Getty Images

News | HIMSS | July 01, 2021